|
Volumn 8, Issue 3, 2012, Pages 282-
|
MenB candidate vaccine Bexsero induces robust immune response in infants.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MENINGOCOCCUS VACCINE;
HUMAN;
IMMUNOLOGY;
INFANT;
MENINGOCOCCOSIS;
MICROBIOLOGY;
NEISSERIA MENINGITIDIS;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
TREATMENT OUTCOME;
CLINICAL TRIALS, PHASE II AS TOPIC;
HUMANS;
INFANT;
MENINGOCOCCAL INFECTIONS;
MENINGOCOCCAL VACCINES;
NEISSERIA MENINGITIDIS, SEROGROUP B;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 84874409731
PISSN: None
EISSN: 2164554X
Source Type: Journal
DOI: 10.4161/hv.19916 Document Type: Note |
Times cited : (1)
|
References (0)
|